Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-060464
Filing Date
2025-06-18
Accepted
2025-06-18 07:00:57
Documents
9
Effectiveness Date
2025-06-18

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2415719d26_s8.htm S-8 95409
2 EXHIBIT 5.1 tm2415719d26_ex5-1.htm EX-5.1 12683
3 EXHIBIT 23.1 tm2415719d26_ex23-1.htm EX-23.1 1807
4 EXHIBIT 23.2 tm2415719d26_ex23-2.htm EX-23.2 1421
5 EXHIBIT 99.2 tm2415719d26_ex99-2.htm EX-99.2 162533
6 EXHIBIT 99.3 tm2415719d26_ex99-3.htm EX-99.3 107711
7 EX-FILING FEES tm2415719d26_ex-filingfees.htm EX-FILING FEES 22990
8 GRAPHIC tm2415719d26_ex5-1img001.jpg GRAPHIC 3542
9 GRAPHIC tm2415719d26_ex5-1img002.jpg GRAPHIC 6015
  Complete submission text file 0001104659-25-060464.txt   419147
Mailing Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039
Business Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039 (866) 771-8946
Caris Life Sciences, Inc. (Filer) CIK: 0002019410 (see all company filings)

EIN.: 852077369 | State of Incorp.: TX | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-288122 | Film No.: 251055110
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)